Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -4.90% | 58.57 | 0.0% | $906.01m | |
| AMGN | Amgen, Inc. | 1.22% | 258.24 | 1.3% | $750.82m | |
| GILD | Gilead Sciences, Inc. | 0.38% | 76.35 | 1.0% | $724.94m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.18% | 622.45 | 2.5% | $659.43m | |
| NVAX | Novavax, Inc. | 2.43% | 81.64 | 102.0% | $580.82m | |
| BIIB | Biogen, Inc. | 0.13% | 265.12 | 1.6% | $559.05m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.68% | 291.10 | 1.9% | $527.74m | |
| ILMN | Illumina, Inc. | 1.24% | 373.10 | 3.5% | $308.62m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.08% | 112.30 | 2.0% | $228.46m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.75% | 126.78 | 4.3% | $214.78m | |
| SGEN | Seattle Genetics, Inc. | 0.90% | 169.03 | 6.1% | $202.30m | |
| SRNE | Sorrento Therapeutics, Inc. | -1.15% | 6.85 | 1.8% | $184.40m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.77% | 162.75 | 13.9% | $167.23m | |
| INCY | Incyte Corp. | 3.72% | 106.47 | 2.5% | $163.35m | |
| IMMU | Immunomedics, Inc. | 1.71% | 37.54 | 11.0% | $159.56m |
Company Profile
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.